1. © 2014 Medidata Solutions, Inc. Can Big Data/Real World Data Cure Life Science’s R&D Malaise? Glen de Vries Founder and President

2. DevelopmentCommercial RegulatorsPayers Efficacy Data Effectiveness Data © 2014 Medidata Solutions, Inc.

3. DevelopmentCommercial RegulatorsPayers The Same Data © 2014 Medidata Solutions, Inc.

4. *omics Clinical mHealth © 2014 Medidata Solutions, Inc.

5. MEDIDATA, AN INTRODUCTION

6. 6

7. ENGAGE, COLLABORATE, INNOVATE

8. The GADGET Method Development Effort + © 2014 Medidata Solutions, Inc.

11. Genetic Biomarkers Phenotypic Biomarkers Digital Biomarkers © 2014 Medidata Solutions, Inc.

12. 12

13. 13

15. The Medidata MOVE-2014 Study © 2014 Medidata Solutions, Inc.

16. SafetyPrivacyRegulation Objections © 2014 Medidata Solutions, Inc.

18. ApprovalPatent Expiration Value (Therapeutic & Economic) Time Baseline Value Commercial Patient Engagement Strategy Clinical Development Patient Engagement Strategy lost annually from patients not taking their medicines £350 Billion Therapeutic Benefits! + © 2014 Medidata Solutions, Inc.

19. There will be life sciences companies using objectively measured digital biomarker data with both regulators and payers… And there will still be life sciences companies that are not 2020 Predictions © 2014 Medidata Solutions, Inc.

20. 10 years from now life sciences companies that don’t use digital biomarkers as part of their solutions will no longer exist © 2014 Medidata Solutions, Inc.

21. Thank you!